Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2775-2026

SnapshotGLO Wound Imaging Device, Model KB100, KB100AA. Recall

SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.

FDA recall Class II

Ongoing

FDA lists this Class II recall for SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2775-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jun 30, 2026
FDA report date
Jul 29, 2026
Quantity in commerce
77
Distribution
See key details
FDA cause
Software design

What is being recalled?

SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.

Affected model & UDI checker

Search the exact identifiers published for Z-2775-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
KB100SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.Check source noticeNot specified
FDA code information

UDI-DI: B376KB1000, Software Revisions v4.2.0 and v4.1.3

View the original FDA recall notice

Why was this product recalled?

The software controlling the wound imaging device's battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power "shipping mode." When this occurs, an affected device will not resume charging when reconnected to power and becomes temporarily unusable/ unavailable for wound imaging until corrected.

What actions did KENT IMAGING, INC. take?

On 6/30/2026, correction and removal notices were emailed to customers who were asked to do the following: 1) Discontinue use of the affected unit(s) and remove them from clinical service. 2) Contact Kent Imaging at customerservice@kentimaging.com to confirm return shipping instructions. 3) Pending return, keep the device charged and avoid allowing the battery to fully deplete, to prevent the unit from becoming temporarily inoperable in the interim. 4) Within 5 business days of receipt of this notice, please confirm receipt and current status of the listed unit(s) by replying to this letter or contacting Hitalo Arume directly. Distributor was asked to: a) Identify the current location/holder of each of these 6 units; b) Coordinate scheduling of a brief remote session between Kent Imaging's technical support team and each unit's user; and c) Confirm completion of each update on the attached Device Reconciliation Form. d) For units that require physical return, quarantine and stop distribution. For units distributed, identify each affected customer, coordinate on-site access for collection, and arrange return shipment to Kent Imaging. Questions can be directed to hitaloa@kentimaging.com

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology